Fusion Antibodies is delighted to be attending this year’s Antibody Engineering and Therapeutics conference in San Diego from 4 – 8 December 2022.

The annual Antibody Engineering and Therapeutics conference has been recognized as the number one antibody engineering conference for accelerating next generation antibodies to commercial success.  

Join Chris Winch commercial director and Chief Scientific Officer Richard Buick as he delivers an exciting briefing on Fusion Antibodies’ leading R&D programme: OptiMAL® – A Novel Library and Mammalian Display Platform for Antibody Discovery (Tuesday December 6th at 12:05pm).  

Find out more about this event here. 

About Fusion Antibodies

Fusion Antibodies are world leaders in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics to clinical Cell Line Development. 

We have guided hundreds of projects through critical pre-clinical stages, repeatedly proving our expertise as we strive to bring about a positive change in the healthcare industry. 

Get in touch below to organise a meeting with one of the Fusion Antibodies team.